4.7 Article

Engineered membrane protein antigens successfully induce antibodies against extracellular regions of claudin-5

Journal

SCIENTIFIC REPORTS
Volume 8, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-26560-9

Keywords

-

Funding

  1. Program for Creating STart-ups from Advanced Research and Technology (START) from Japan Science and Technology Agency, JST
  2. Health and Labour Sciences Research Grant from the Japan Agency for Medical Research and Development (AMED) [JP15ak0101007]
  3. Japan Society for the Promotion of Science (JSPS) KAKENHI grant [24390042, 16K01915, 17K19487]
  4. Platform for Drug Discovery, Informatics, and Structural Life Science (PDIS) from AMED
  5. Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED
  6. SENSIN Medical Research Foundation
  7. Takeda Science Foundation
  8. Research Fellowship for Young Scientists from JSPS [15J10065]
  9. Grants-in-Aid for Scientific Research [16K01915, 17K19487, 15J10065] Funding Source: KAKEN

Ask authors/readers for more resources

The production of antibodies against the extracellular regions (ECR) of multispanning membrane proteins is notoriously difficult because of the low productivity and immunogenicity of membrane proteins due to their complex structure and highly conserved sequences among species. Here, we introduce a new method to generate ECR-binding antibodies utilizing engineered liposomal immunogen prepared using a wheat cell-free protein synthesis system. We used claudin-5 (CLDN-5) as the target antigen, which is a notoriously difficult to produce and poorly immunogenic membrane protein with two highly conserved extracellular loops. We drastically improved the productivity of CLDN-5 in the cell-free system after suppressing and normalizing mRNA GC content. To overcome its low immunogenicity, two engineered antigens were designed and synthesized as proteoliposomes: a human/mouse chimeric CLDN-5, and a CLDN-5-based artificial membrane protein consisting of symmetrically arranged ECRs. Intraperitoneal immunization of both engineered CLDN-5 ECR antigens induced ECR-binding antibodies in mice with a high success rate. We isolated five monoclonal antibodies that specifically recognized CLDN-5 ECR. Antibody clone 2B12 showed high affinity (< 10 nM) and inhibited CLDN-5-containing tight junctions. These results demonstrate the effectiveness of the methods for monoclonal antibody development targeting difficult-to-produce membrane proteins such as CLDNs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available